Dynamics of the incidence of acute and chronic inflammatory polyneuropathies in adults in the Leningrad region

Dynamics of the incidence of acute and chronic inflammatory polyneuropathies in adults in the Leningrad region

Background. Inflammatory polyneuropathies (IPNP) are diseases caused by an immune response against antigens in the peripheral nervous system. Epidemiological research is essential for health resource planning.Objective: to assess the clinical and epidemiological characteristics of acute and chronic...

Full description

Bibliographic Details
Main Authors:	E. A. Skornyakova, L. G. Zaslavskii
Format:	Article
Language:	Russian
Published:	ABV-press 2021-04-01
Series:	Nervno-Myšečnye Bolezni
Subjects:	inflammatory polyneuropathies guillain–barré syndrome chronic inflammatory demyelinating polyneuropathy incidence leningrad region
Online Access:	https://nmb.abvpress.ru/jour/article/view/425

Similar Items

A Severe Course of Relapsing-Remitting Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy in a Young Man
by: Anna P. Patnaik, et al.
Published: (2021-02-01)

Acute‐onset chronic inflammatory demyelinating polyneuropathy with cranial nerves and respiratory tract involvement: A case report
by: Malek Mansour, et al.
Published: (2020-11-01)

Atypical Chronic Inflammatory Demyelinating Polyneuropathy
by: J Gordon Millichap
Published: (2010-11-01)

Clinical heterogeneity of chronic inflammatory demyelinating polyneuropathy: diagnostic challenges
by: A. S. Rizvanova, et al.
Published: (2020-03-01)

Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy
by: Alanood Alsolaihim, et al.
Published: (2020-02-01)

Depression with chronic inflammatory demyelinating polyneuropathy
by: Arun Marwale, et al.
Published: (2018-01-01)

Steroids for Chronic Inflammatory Demyelinating Polyneuropathy
by: J Gordon Millichap
Published: (2005-03-01)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in a Patient with Diabetes: a primary care perspective
by: Jordan Dever, et al.
Published: (2020-10-01)

Guillain-Barré Syndrome During Active Brucellosis
by: Recep Aygul, et al.
Published: (2010-12-01)

Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy
by: Rajabally YA, et al.
Published: (2020-09-01)

Role of “Sural Sparing” Pattern (Absent/Abnormal Median and Ulnar with Present Sural SNAP) Compared to Absent/Abnormal Median or Ulnar with Normal Sural SNAP in Acute Inflammatory Demyelinating Polyneuropathy
by: Spurthi Sunil Surpur, et al.
Published: (2017-09-01)

Chronic inflammatory demyelinating polyneuropathy in children: a report of four patients with variable relapsing courses
by: Soo Jin Chang, et al.
Published: (2015-05-01)

Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
by: Tomohiro Hayashi, et al.
Published: (2021-05-01)

Neurofascin and Compact Myelin Antigen-Specific T Cell Response Pattern in Chronic Inflammatory Demyelinating Polyneuropathy Subtypes
by: Jan-Markus Diederich, et al.
Published: (2018-03-01)

Anaesthetic management and implications of a case of chronic inflammatory demyelinating polyneuropathy
by: Babita Gupta, et al.
Published: (2011-01-01)

Treatment of pediatric chronic inflammatory demyelinating polyneuropathy: Challenges, controversies, and questions
by: Jay Desai, et al.
Published: (2015-01-01)

Comprehensive approaches for diagnosis, monitoring and treatment of chronic inflammatory demyelinating polyneuropathy
by: Anna Lena Fisse, et al.
Published: (2020-12-01)

Childhood subacute inflammatory demyelinating polyneuropathy
by: Chia-Yu Hsu, et al.
Published: (2011-11-01)

Chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus
by: Farzad Fatehi, et al.
Published: (2013-01-01)

Guillain–Barre syndrome as the first manifestation of juvenile systemic lupus erythematosus: a case report
by: Javadi Parvaneh V, et al.
Published: (2019-04-01)

Two comparative assessments of intravenous immunoglobulin therapy switching patterns in the treatment of chronic inflammatory demyelinating polyneuropathy in the US
by: Guptill JT, et al.
Published: (2019-04-01)

Diagnostic transcranial magnetic stimulation in children with acute inflammatory demyelinating polyneuropathy
by: V. B. Voitenkov, et al.
Published: (2016-07-01)

Lumbosacral motor polyneuropathy
by: S. A. Malmberg, et al.
Published: (2015-02-01)

Fatigue in patients with chronic inflammatory demyelinating polyneuropathy
by: R. A. Gapeshin, et al.
Published: (2021-02-01)

Missed diagnosis of chronic inflammatory demyelinating polyneuropathy in a patient with cervical myelopathy due to ossification of posterior longitudinal ligament
by: Min Cheol Chang
Published: (2018-10-01)

Immunoadsorption and Plasma Exchange in Seropositive and Seronegative Immune-Mediated Neuropathies
by: Alexander J. Davies, et al.
Published: (2020-06-01)

Subacute Demyelinating Polyneuropathy
by: J Gordon Millichap
Published: (2005-06-01)

Immune Cell Profiling of the Cerebrospinal Fluid Provides Pathogenetic Insights Into Inflammatory Neuropathies
by: Michael Heming, et al.
Published: (2019-03-01)

Anesthetic management of a patient with chronic inflammatory demyelinating polyneuropathy by combination of total intravenous and regional anesthesia
by: Daiki Takekawa, et al.
Published: (2019-03-01)

EXPERIENCE IN THE USE OF PLASMAPHERESIS IN ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY GUILLAIN – BARRE SYNDROME IN THE PATIENT WITH CHRONIC HEPATITIS C VIRUS INFECTION AND TYPE 2 DIABETES MELLITUS
by: V. A. Voinov, et al.
Published: (2018-12-01)

Treatment-related fluctuations in guillain barre syndrome and the conundrum of additional cycles of plasmapheresis
by: Subasree Ramakrishnan, et al.
Published: (2017-01-01)

Novel pathomechanisms in inflammatory neuropathies
by: David Schafflick, et al.
Published: (2017-11-01)

PATHOGENESIS, CLINICAL AND LABORATORY FEATURES OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
by: R. A. Gapeshin, et al.
Published: (2018-12-01)

Specific features of chronic inflammatory demyelinating polyneuropathy in children
by: A. L. Kurenkov, et al.
Published: (2015-02-01)

The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with diabetes mellitus
by: R. A. Gapeshin, et al.
Published: (2020-06-01)

Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
by: Chafké Belmokhtar, et al.
Published: (2019-03-01)

Chronic inflammatory demyelinating polyneuropathy with hypoglossal nerve involvement and inverted Beevor’s sign: case report
by: Huajian Zhao, et al.
Published: (2021-06-01)

Epidemiology of chronic inflammatory demyelinating polyneuropathy abroad and in Russia
by: T. E. Popova, et al.
Published: (2015-06-01)

Autoantibodies Against the Node of Ranvier in Seropositive Chronic Inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic Relevance
by: Atay Vural, et al.
Published: (2018-05-01)

CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY IN CHILDREN: DIAGNOSIS AND TREATMENT
by: А.L. Kurenkov, et al.
Published: (2014-10-01)